These findings suggest that patients with the smaller response on glycaemic control and, hence, with persistently higher HbA1c requiring more aggressive treatment, including insulin, are those at higher risk of hypoglycaemia and death, pointing to a more complex relationship among hypoglycaemia, achieved HbA1c, and treatment intensity. This evidence concerns the gene INS and Hypoglycemia.